Skip to main content

Table 2 Facilitators and barriers to harm reduction services, stratified by dimensions of access

From: The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in a rural American state

Dimension of access

Description of dimension

Facilitators

Barriers

Accessibilityb

Getting to service (i.e., location, transportation issues)

Mobile SSPsa

Outdoor services

Mailing equipment

COVID-19 screening

No cell phone coverage

Inclement weather

Masking requirements on buses

Changing locations

Availabilityb

Supply and demand

Relaxed policies

SSPs sharing supplies

Stricter adherence to 1:1 needle exchange

Increased drug use

Lack of safe supply

Acceptabilityb

How clients perceive service

Face to face outreach

Trust established before pandemic

Relaxed policies

Mobile outreach

Masking

Social distancing policies (i.e., waiting in line)

Stigma

Lack of trust/difficult to establish trust under lockdown

Law enforcement

Affordabilityb

Ability of clients to pay for service

Relaxed policies (i.e., elimination of 1:1 needle exchange)

Unemployment

Higher drug costs

Requiring one-for-one needle exchange

Accommodationb

Hours of service provision, structure of services, facilities

Community resilience/Staff working more hours

COVID-19 screening

Limited service hours

Appointment-only for health services

Awarenessc

Communication and information about services

Outreach

Flyers mailed with supplies

Miscommunication around changing policies

Changing locations

Restrictions on outreach workers in certain locations (i.e., jails)

  1. aSSP, syringe service program
  2. bFive dimensions of access described by Penchansky and Thomas
  3. cSixth dimension of access described by Saurman